GeM_(10)体外对PHA诱发的肿瘤病人外周血单个核细胞产生IL-2的影响  被引量:1

Promotion of GeM 10 on the IL-2 production by peripheral blood mononuclear cells in Vitro

在线阅读下载全文

作  者:陈静宏[1,2] 陈高平[1,2] 苏敏 魏西秦[1,2] 张健 

机构地区:[1]西安医科大学地方性骨病研究所 [2]西安医科大学基础医学院

出  处:《微量元素与健康研究》1999年第1期13-15,共3页Studies of Trace Elements and Health

摘  要:GeM10是一种抗癌生物碱-金属配位药物,动物实验发现GeM10对实验肿瘤S180肉瘤有抑制作用,能明显延长艾氏腹水癌荷瘤小鼠的存活时间,封闭荷瘤鼠体单核巨噬细胞系统,GeM10的抑癌作用解除。观察了GeM10对PHA诱发的肿瘤患者外周血单个核细胞(PBMC)产生白介素-2(IL-2)能力的影响。结果发现GeM10能提高肿瘤患者外周血单个核细胞产生白细胞介素-2的能力(对照组:1.792±0.823;GeM1060μg/ml2.965±1.183;P<0.05)。提示:GeM10的抗癌作用与其刺激机体免疫活性细胞。GeM 10 is a new organic germanium compound-alkalaid-metal complex.Our previous date showed that GeM 10 could inhibited S 180 Solid tumor and Ehrilish ascites in mice.Although GeM 10 showed strong antitumor effect in Vivo,the mechanism of the antitumor effect is still unclear.in this paper,We studied the cytokine(IL 2) production by the peripheral blood mononuclear cells(PBMC) by Il 2 dependent cell line CTLL 2 and MTT colorometric method.It is observed that GeM 10 could enhanced the IL 2 production of peripheral blood mononuclear cells of 12 tumor patients (control:1.792+0.823 to 60μg/ml GeM 10 2.965=1.183 P<0 05).these finding suggest that GeM 10 can inhibit the tumor growth and may have promise as a antitumor drug and biological response modifier in humans

关 键 词:GeM10 IL-2 肿瘤 金属配位药物 单个核细胞 

分 类 号:R730.53[医药卫生—肿瘤] R979.1[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象